Ihr Suchergebnis
Sie recherchieren derzeit unangemeldet.Melden Sie sich an (Login) um den vollen Funktionsumfang der Datenbank nutzen zu können.
In der Rubrik News haben wir 23162 Angebote für Sie gefunden
-
Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results
28.04.2025Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growth
-
GlymaxX®-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy
28.04.2025ProBioGen recognizes the significance of the commercial availability of Ziihera® (zanidatamab-hrii), a therapeutic antibody developed using ProBioGen's proprietary GlymaxX® technology. In addition, ProBioGen also developed the...
-
Neurizon Strengthens Leadership Team with Strategic Regulatory and Scientific Appointments
28.04.2025Neurizon® makes three key executive appointments: Ms Kathryn Williams as Chief Regulatory Officer, Dr Jeffrey M. Brown as Chief Scientific Advisor, and Dr Chris Freitag as Chief Medical Advisor
-
Eleva Publishes Evidence of Immunomodulation and Neuroprotection Using its Factor H Biological Therapy in Preclinical Dry AMD Study
28.04.2025Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, announced today the publication of...
-
Capricorn Scientific and florabio Join Forces to Revolutionize Cell Culture Media in Biotech and Vaccine Industry with Animal-Free, High-Yield Solutions
28.04.2025Capricorn Scientific GmbH, a leading provider of sterile cell culture media and animal-free powders for the biotech and diagnostics industries, proudly announces an...
-
Evotec SE unveils new strategy and provides 2025 guidance bolstered by strong Q4 2024 results
24.04.2025Evotec sharpens focus on pioneering drug discovery and charts clear path toward sustainable profitable growth
-
Biotech-Firma mit Fokus auf Übergewicht: Wir streben einen Vertragsabschluss innerhalb weniger Jahre an
24.04.2025Das in Dänemark gegründete Biotech-Unternehmen Pila Pharma verfolgt das Ziel, in den kommenden Jahren eine Partnerschaft einzugehen oder übernommen zu werden. Kurzfristig liegt der Fokus auf der Weiterentwicklung eines vielversprechenden neuen Arzneimittelkandidaten zur Behandlung von Übergewicht und Diabetes.
-
Innovation im Gesundheitswesen: IQVIA & EMA Gemeinsam gegen den Medikamentenmangel
24.04.2025IQVIA hat mit der Europäischen Arzneimittel-Agentur EMA jetzt eine langfristige Vereinbarung geschlossen und unterstützt damit...
-
AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development
24.04.2025Funding from SPRIND and Family Offices accelerates preparation of ATL-105 for clinical development in lead indication non-CF related bronchiectasis by 2026
-
Chemeleon to Collaborate with Mayo Clinic to Finalize Ultra-Rapid Assay, Opens $10M Series A
24.04.2025Chemeleon, a disruptive innovator in diagnostic technology, today announced a collaboration with Mayo Clinic to complete development and clinical validation of their ultra-rapid, instrument-free assay poised to redefine point-of-care (POC) testing in emergency settings. This collaboration will focus on clinical optimization of Chemeleon’s flagship high-sensitivity cardiac troponin (hs-cTn) assay and explore the application of their platform technology to other acute care conditions beyond cardiac care. Coinciding with this milestone, the company has opened a $10M Series A funding round to help bring this transformative technology to market.
Sie sehen Artikel 3381 bis 3390 von insgesamt 23162
- Erste Seite
- 337
- 338
- 339
- 340
- 341
- Letzte Seite
